Regarding trisomy 18 [1]

American Journal of Medical Genetics

Volumn 140 A, Issue 9, 2006, Pages 964-965

  Lebel, Robert Roger ^a   Roberson, Jacquelyn ^b   Van Dyke, Daniel L ^c  

^a GREENWOOD GENETIC CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; CHILD GROWTH; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GUILT; HEARING IMPAIRMENT; HUMAN; KYPHOSCOLIOSIS; LETTER; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TRISOMY 18; CHROMOSOME 18; FATALITY; GENETICS; MULTIPLE MALFORMATION SYNDROME; NOTE; PATHOLOGY; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; TRISOMY;

ABNORMALITIES, MULTIPLE; ADULT; CHROMOSOMES, HUMAN, PAIR 18; FATAL OUTCOME; FEMALE; HUMANS; SOCIAL SUPPORT; TRISOMY;

EID: 33646092293     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31170     Document Type: Letter

References (4)

1. Carey J. 1992. Health supervision and anticipatory guidance for children with genetic disorders (including specific recommendations fortrisomy 21, trisomy 18, and neurofibromatosis I). Pediatr Clin North Am 39:25-53.
2. Kelly M, Robinson BW, Moore JW. 2002. Trisomy 18 in a 20-year-old woman. Am J Med Genet 112:397-399.
3. McClatchey KD. 2002. Chapter 30 Clinical Cytogenetics. In: Van Dyke DL, Wiktor A. editors. Clinical laboratory medicine (Second Edition) Philadelphia: Lippincott Williams & Wilkins. p618.
4. Van Dyke DC, Allen M. 1990. Clinical management considerations in long-term survivors with trisomy 18. Pediatrics 85:753-759.